Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer.

Noordman, B J; Wijnhoven, B P L; Lagarde, S M; Biermann, K; van der Gaast, A; Spaander, M C W; Valkema, R; van Lanschot, J J B

Noordman, B J; Wijnhoven, B P L; Lagarde, S M; Biermann, K; van der Gaast, A; Spaander, M C W; Valkema, R; van Lanschot, J J B.

Afiliação

Noordman BJ; Department of Surgery.
Wijnhoven BPL; Department of Surgery.
Lagarde SM; Department of Surgery.
Biermann K; Department of Pathology.
van der Gaast A; Department of Medical Oncology.
Spaander MCW; Department of Gastroenterology.
Valkema R; Department of Radiology and Nuclear Medicine, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
van Lanschot JJB; Department of Surgery.

Dis Esophagus ; 30(12): 1-8, 2017 Dec 01.

Article em En | MEDLINE | ID: mdl-28881890

Assuntos

Neoplasias Esofágicas/terapia; Junção Esofagogástrica; Conduta Expectante; Quimiorradioterapia Adjuvante; Esofagectomia; Humanos; Terapia Neoadjuvante; Resultado do Tratamento

Palavras-chave

esophageal cancer surveillance; esophagectomy; neoadjuvant chemoradiation; response evaluation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Junção Esofagogástrica / Conduta Expectante Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google